Inflammatory Response and Activation of Coagulation after COVID-19 Infection

Area of Science:

• Infectious Diseases
• Hematology
• Immunology

Background:

• COVID-19 presents with diverse clinical manifestations, including a predisposition to thromboembolic disease.
• Excessive inflammation is a key factor contributing to the thrombotic complications observed in SARS-CoV-2 infection.

Approach:

• A retrospective cohort study analyzed 97 hospitalized COVID-19 patients.
• Medical records were reviewed to assess clinical and laboratory data, including cytokine levels and thrombosis occurrence.
• Patients were categorized into groups with and without thrombotic events for comparative analysis.

Key Points:

• Seven cases of thrombotic events were identified in the cohort.
• Patients with thrombosis exhibited reduced prothrombin activity and elevated levels of IL-1b, IL-10, and IL-2 (p < 0.05).
• Thrombocytopenia was present in 27.8% of all patients.

Conclusions:

• Hospitalized COVID-19 patients with thrombotic events demonstrate an increased inflammatory response.
• Elevated serum cytokine levels, specifically IL-10, are associated with a higher likelihood of thrombotic events in this population.